Literature DB >> 3083895

Biallelic heavy chain immunoglobulin gene rearrangement in acute nonlymphocytic leukemia.

C R Bartram, A Raghavachar, H Heimpel.   

Abstract

Acute nonlymphocytic leukemia (ANLL) was diagnosed in 18 patients based on morphological, cytochemical and immunological criteria. Leukemic cells of these cases were subjected to Southern blot analysis and subsequent hybridization to heavy chain immunoglobulin and T-cell-receptor gene probes. A rearrangement within the immunoglobulin joining region was detected in 2 cases, while the T-cell-receptor beta-chain gene was in germline configuration in all samples investigated. These data confirm recent reports indicating that immunoglobulin heavy chain gene rearrangements are not restricted to B-lineage neoplasms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3083895     DOI: 10.1007/bf00321079

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  24 in total

1.  A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage.

Authors:  C S Abramson; J H Kersey; T W LeBien
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

2.  A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.

Authors:  E D Ball; R F Graziano; M W Fanger
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

3.  Immunoglobulin gene rearrangement in acute myelogenous leukemia.

Authors:  K Ha; M Minden; N Hozumi; E W Gelfand
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

4.  M2, a novel myelomonocytic cell surface antigen and its distribution on leukemic cells.

Authors:  O Majdic; P Bettelheim; H Stockinger; W Aberer; K Liszka; D Lutz; W Knapp
Journal:  Int J Cancer       Date:  1984-05-15       Impact factor: 7.396

5.  Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms.

Authors:  A Arnold; J Cossman; A Bakhshi; E S Jaffe; T A Waldmann; S J Korsmeyer
Journal:  N Engl J Med       Date:  1983-12-29       Impact factor: 91.245

6.  [Diagnosis of leukemia with monoclonal antibodies].

Authors:  O Majdic; P Bettelheim; K Liszka; D Lutz
Journal:  Wien Klin Wochenschr       Date:  1982-08-06       Impact factor: 1.704

7.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

8.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22.

Authors:  J Groffen; J R Stephenson; N Heisterkamp; A de Klein; C R Bartram; G Grosveld
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

9.  Expression of myeloid differentiation antigens on normal and malignant myeloid cells.

Authors:  J D Griffin; J Ritz; L M Nadler; S F Schlossman
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

10.  Antigens on human monocytes identified by monoclonal antibodies.

Authors:  R F Todd; L M Nadler; S F Schlossman
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

View more
  3 in total

1.  Immunoglobulin gene transcripts have distinct VHDJH recombination characteristics in human epithelial cancer cells.

Authors:  Jie Zheng; Jing Huang; Yuntao Mao; Shiqing Liu; Xin Sun; Xiaohui Zhu; Teng Ma; Li Zhang; Jiafu Ji; Youhui Zhang; C Cameron Yin; Xiaoyan Qiu
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

2.  IgD/lambda plasmocytoma with immunoglobulin kappa light-chain genes in the germ-line configuration.

Authors:  G Hauke; J T Epplen; J Chluba; A Hollmann; H H Peter
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

3.  Acute leukemia with chromosome translocation (4;11): 7 new patients and analysis of 71 cases.

Authors:  F Lampert; J Harbott; W D Ludwig; C R Bartram; J Ritter; V Gerein; M Neidhardt; R Mertens; N Graf; H Riehm
Journal:  Blut       Date:  1987-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.